RUX may represent a valuable therapeutic option for some patients with advanced SR-aGVHD
Thats the best part.
Geeez.
Aloha.
Ann: Mesoblast Partners with BMT CTN on Adult SR-aGVHD Trial, page-263
-
- There are more pages in this discussion • 100 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.15 |
Change
0.020(1.78%) |
Mkt cap ! $1.307B | |||
| Open | High | Low | Value | Volume |
| $1.13 | $1.18 | $1.13 | $1.982M | 1.718M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 15 | 58625 | $1.14 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.15 | 18811 | 13 |
View Market Depth
| Last trade - 11.50am 30/09/2024 (20 minute delay) ? |
| MSB (ASX) Chart |